Literature DB >> 18420689

Knowing me, knowing you.

Jeanne Lenzer1, Shannon Brownlee.   

Abstract

Mesh：

Year:  2008        PMID： 18420689      PMCID： PMC2323079          DOI： 10.1136/bmj.39534.451458.AD

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  8 in total

1.  The genome gets personal--almost.

Authors:  W Gregory Feero; Alan E Guttmacher; Francis S Collins
Journal:  JAMA       Date:  2008-03-19       Impact factor: 56.272

2.  Uncertainties in genetic testing for chronic disease.

Authors:  H G Welch; W Burke
Journal:  JAMA       Date:  1998-11-04       Impact factor: 56.272

3.  Treatment complications in children diagnosed with neuroblastoma during a screening program.

Authors:  Stéphane Barrette; Mark L Bernstein; Jean-Marie Leclerc; Martin A Champagne; Yvan Samson; Josée Brossard; William G Woods
Journal:  J Clin Oncol       Date:  2006-04-01       Impact factor: 44.544

4.  The impact of the introduction of a rapid D-dimer assay on the diagnostic evaluation of suspected pulmonary embolism.

Authors:  N M Goldstein; M H Kollef; S Ward; B F Gage
Journal:  Arch Intern Med       Date:  2001-02-26

5.  Screening of infants and mortality due to neuroblastoma.

Authors:  William G Woods; Ru-Nie Gao; Jonathan J Shuster; Leslie L Robison; Mark Bernstein; Sheila Weitzman; Greta Bunin; Isra Levy; Josee Brossard; Geoffrey Dougherty; Mendel Tuchman; Bernard Lemieux
Journal:  N Engl J Med       Date:  2002-04-04       Impact factor: 91.245

Review 6.  Delivery of genomic medicine for common chronic adult diseases: a systematic review.

Authors:  Maren T Scheuner; Pauline Sieverding; Paul G Shekelle
Journal:  JAMA       Date:  2008-03-19       Impact factor: 56.272

7.  Computed tomography screening and lung cancer outcomes.

Authors:  Peter B Bach; James R Jett; Ugo Pastorino; Melvyn S Tockman; Stephen J Swensen; Colin B Begg
Journal:  JAMA       Date:  2007-03-07       Impact factor: 56.272

8.  Recommendations from the EGAPP Working Group: testing for cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors.

Authors: 
Journal:  Genet Med       Date:  2007-12       Impact factor: 8.822
  8 in total
  5 in total

1.  Impact of direct-to-consumer predictive genomic testing on risk perception and worry among patients receiving routine care in a preventive health clinic.

Authors:  Katherine M James; Clayton T Cowl; Jon C Tilburt; Pamela S Sinicrope; Marguerite E Robinson; Katrin R Frimannsdottir; Kristina Tiedje; Barbara A Koenig
Journal:  Mayo Clin Proc       Date:  2011-10       Impact factor: 7.616

Review 2.  The regulation of direct-to-consumer genetic tests.

Authors:  Jane Kaye
Journal:  Hum Mol Genet       Date:  2008-10-15       Impact factor: 6.150

3.  Breast cancer in the personal genomics era.

Authors:  Rachel E Ellsworth; David J Decewicz; Craig D Shriver; Darrell L Ellsworth
Journal:  Curr Genomics       Date:  2010-05       Impact factor: 2.236

4.  Current State and Future Prospects of Direct-to-Consumer Pharmacogenetics.

Authors:  E W Chua; M A Kennedy
Journal:  Front Pharmacol       Date:  2012-08-20       Impact factor: 5.810

Review 5.  The past, present, and future of direct-to-consumer genetic tests.

Authors:  Agnar Helgason; Kári Stefánsson
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.